The Usability Evaluation of the Usefulness of Bismuth Shields in PET/CT Examination

PET/CT 검사에서 비스무스(bismuth) 차폐체의 적용에 따른 유용성 평가

  • Park, Hoon-Hee (Department of Radiological Technology, Shingu College) ;
  • Lee, Juyoung (Graduate School of Public Health, Yonsei Universtiy) ;
  • Kim, Ji-Hyeon (Department of Nuclear Medicine, Seoul Medical Center) ;
  • Nam, Kun-Sik (Department of Nuclear Medicine, Konkuk University Medical Center) ;
  • Lyu, Kwang-Yeul (Department of Radiological Technology, Shingu College) ;
  • Lee, Tae Soo (Department of Biomedical Enginnering, Chugnbuk National University)
  • Received : 2014.01.03
  • Accepted : 2014.03.03
  • Published : 2014.03.31

Abstract

Recently with CT developed, various studies for reduction of exposure dose is underway. Study of bismuth shields in these studies is actively underway, and has already been applied in the clinical. However, the application of the PET/CT examination was not activated. Therefore, through this study, depending on the application of bismuth shields in the PET/CT examination, we identify the quality of the image and the impact on the Standard Uptake Value (SUV). In this study, to apply to the shielding of the breast, by using the bismuth shields that contains 0.06 mm Pb ingredients, was applied to the PET/CT GEMINI TF 64 (Philips Healthcare, Cleveland, USA). Phantom experiments using the NEMA IEC Body Phantom, images were acquired according to the presence or absence of bismuth shields apply. Also, When applying, images were obtained by varying the spacing 0, 1, 2 cm each image set to the interest range in the depth of the phantom by using EBW-NM ver.1.0. When image of the PET Emission acquires, the SUV was in increased depending on the use of bismuth shields, difference in the depth to the surface from deep in the phantom increasingly SUV increased (P<0.005). Also, when using shields, as the more gab decreased, SUV is more increased (P<0.005). Through this study, PET/CT examination by using of bismuth shields which is used as purpose of reduction dose. When using shields, the difference of SUV resulting from the application of bismuth shields exist and that difference when gab is decrease and surface is wider. Therefore, setting spacing of shield should be considered, if considering the reduction of the variation of SUV and image quality, disease of deep organs should be a priority rather than superficial organ disease. Use of bismuth shielding factor considering the standard clinical examination, decrease unnecessary exposure can be expected to be considered.

최근 PET/CT는 CT의 발전과 함께, 피폭선량의 저감화를 위한 다양한 연구가 진행되고 있다. 이러한 연구 중 비스무스(bismuth) 차폐체에 관한 연구가 활발하게 진행 중이지만 현재 PET/CT 검사에서의 적용은 활성화 되지 않았다. 그러므로 본 연구를 통하여 PET/CT 검사에서의 비스무스 차폐체의 적용에 따라 영상의 질과, 표준화섭취계수(SUV)에 미치는 영향을 확인하는데 목적을 두었다. 유방차폐의 적용을 위해 0.06 mm Pb 성분을 포함하고 있는 비스무스 차폐체(AttenuRad_F&L Medical Product Co, USA)를 사용하여 PET/CT 장비 GEMINI TF 64(Philips Healthcare, Cleveland, USA)에 적용하였다. 실험은 NEMA IEC Body Phantom을 사용하여 비스무스 차폐체 적용 유무에 따른 영상을 획득하였다. 또한 적용 시에는 0cm, 1cm, 2cm의 간격 변화를 주어 영상을 획득하였고, 각각의 영상을 EBW(Extended Brilliance Workstation)NM ver.1.0을 이용 팬텀의 Depth에 다른 관심영역을 설정하고 표준섭취계수를 각각 10회씩 측정, 분석하였다. 또한 SPSS ver.18을 통해 통계 분석하였다. PET의 방출(Emission)영상 획득 시 비스무스 차폐체의 적용으로 발생한 방사선 경화현상에 기인하여 표준섭취계수가 증가한 것을 확인하였으며(P<0.005), 깊이에 따른 차이는 팬텀의 심부에서 표면으로 갈수록 표준섭취계수가 증가하였다(P<0.005). 또한 차폐체 사용 시 간격이 줄어들수록 표준섭취계수가 증가하는 것을 확인하였다(P<0.005). 본 연구를 통해 피폭저감을 목적으로 사용하는 비스무스 차폐체의 PET/CT에서의 검사에 적용을 고려할 수 있다. 차폐체 적용에 따른 표준섭취계수의 차이가 존재하며 그 차이는 차폐체와 표면의 간격이 넓을수록 줄어든다. 그러므로 차폐체의 충분한 간격 설정이 고려되어야 할 것이며, 영상의 질과 표준섭취계수 편차의 감소를 고려한다면, 질환에 따라 표재성 질환보다는 심부나 타 장기의 적용이 우선시 되어야 할 것이다. 또 한 비스무스차폐체 사용에 따른 표준섭취계수를 감안한 임상 검사 적용 시, 불필요한 피폭감소 효과를 기대할 수 있을 것으로 사료된다.

Keywords

References

  1. Lynne M.Hurwitz, Terry T.Yoshizumi et al.: Radiation Dose Savings for Adult Pulmonary Embolus 64-MDCT Using Bismuth Breast Shields, Lower Peak Kilovoltage, and Automatic Tube Current Modulation. AJR Am J Roentgenol. 192(1), 244-53, 2009 https://doi.org/10.2214/AJR.08.1066
  2. Bradley L.Fricke, Lane F.Donnelly et al.: In-Plane Bismuth Breast Shields for Pediatric CT : Effects on Radiation Dose and Image Quality Using Experimental and Clinical Data. AJR Am J Roentgenol, 180, 407-411, 2003 https://doi.org/10.2214/ajr.180.2.1800407
  3. Leslie C. Chatterson, MD et al.: Lead versus Bismuth-antimony Shield for Fetal Dose Reduction at Different Gestational Ages at CT Pulmonary Angiography. Radiology, 260(2), 560-7, 2011 https://doi.org/10.1148/radiol.11101575
  4. Fergus V.Coakley et al : CT Radiation Dose : What Can You Do Right Now in Your Practice, AJR Am J Roentgenol, 196, 619-625, 2011 https://doi.org/10.2214/AJR.10.5043
  5. Sangroh Kim et al.: Bismuth Shielding in CT: support for use in children. Pediatric Radiology, 40(11), 1739-1743, 2010 https://doi.org/10.1007/s00247-010-1807-3
  6. Kosuke Matsubara et al.: Effective dose evaluation of multidetector CT examinations : influence of the ICRP recommendation in 2007. Eur Radiol. 19(12), 2855-2861, 2009 https://doi.org/10.1007/s00330-009-1497-0
  7. Kenneth D.Hopper, MD et al.: The Breast : In-plane X-ray Protection during Diagnostic Thoracic CT-Shielding with Bismuth Radioprotective Garments. Radiology. 205(3), 853-258, 1997 https://doi.org/10.1148/radiology.205.3.9393547
  8. RNSA News. Available at : http://www.rsna.org/News Detail.aspx?id=1678. Accessed Sept. 2012
  9. Fred A. Mettler, Jr, MD, MPH et al.: Effective Doses in Radiology and Diagnostic Nuclear Medicine: A Catalog1. Radiology. 248(1), 2008
  10. Karen E. Thomas, Bo Wang.: Age-specific effective doses for pediatric MSCTexaminations at a large children's hospital using DLP conversion coefficients: a simple estimation method, Pediatr Radiol, 38, 645-656, 2008
  11. ICRP 106. Radiation Dose to Patients from Radio pharmaceuticals, ICRP, 2007
  12. ICRP 80. Radiation Dose to Patients from Radio pharmaceuticals, ICRP, 1997
  13. ICRP 103. The 2007 Recommendations of the International Commission on Radiological Protection, ICRP, 2007